Journal of Clinical Epidemiology
Volume 57, Issue 11 , Pages 1182-1187 , November 2004

Most severe neutropenia in individuals with no chronic condition did not result in a specific diagnosis

  • Diana B. Petitti

      Affiliations

    • Kaiser Permanente Medical Care Program, Southern California, 393 East Walnut Street, Pasadena, CA 91188, USA
    • Corresponding Author InformationCorresponding author. Tel.: 626-564-3460; fax: 626-564-3430.
    • ,
  • Richard Contreras

      Affiliations

    • Kaiser Permanente Medical Care Program, Southern California, 393 East Walnut Street, Pasadena, CA 91188, USA
    • ,
  • Michael Glowalla

      Affiliations

    • Kaiser Permanente Medical Care Program, Southern California, 393 East Walnut Street, Pasadena, CA 91188, USA
    • ,
  • Robert Miday

      Affiliations

    • Procter & Gamble Pharmaceuticals, Cincinnati, Ohio, USA

,Accepted 17 April 2004.

References 

  1. Bottiger LE, Bottiger B. Incidence and cause of aplastic anemia, hemolytic anemia, agranulocytosis and thrombocytopenia. Acta Med Scand. 1981;210:475–479
  2. Danielson DA, Douglas SW, Herzog P, Jick H, Porter JB. Drug-induced blood disorders. JAMA. 1984;252:3257–3260
  3. Shapiro S, Issaragrisil S, Kaufman DW, Anderson T, Chansung K, Thamprasit T, et al. Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Am J Trop Med Hyg. 1999;60:573–577
  4. Kaufman DW, Kelly JP, Jurgelon JM, Anderson T, Issaragrisil S, Wiholm BE, et al. Drugs in the aetiology of agranulocytosis and aplastic anaemia. Eur J Haematol Suppl. 1996;60:23–30
  5. Strom BL, Carson JL, Schinnar R, Snyder ES, Shaw M. Descriptive epidemiology of agranulocytosis. Arch Intern Med. 1992;152:1475–1480
  6. Van der Klauw MM, Goudsmit R, Halie MR, van't Veer MB, Herings RM, Wilson JH, et al. A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med. 1999;159:369–374
  7. Rawson NS, Harding SR, Malcolm E, Lueck L. Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: incidence and associations with antecedent prescription drug use. J Clin Epidemiol. 1998;51:1343–1355
  8. Benichou C, Solal Celigny P. Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting. Nouv Rev Fr Hematol. 1991;33:257–262

PII: S0895-4356(04)00120-9

doi: 10.1016/j.jclinepi.2004.04.006

Journal of Clinical Epidemiology
Volume 57, Issue 11 , Pages 1182-1187 , November 2004

Article Tools

* Image Usage & Resolution